121 related articles for article (PubMed ID: 21242806)
21. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice.
Wu DJ; Xu JZ; Wu YJ; Jean-Charles L; Xiao B; Gao PJ; Zhu DL
Atherosclerosis; 2009 Nov; 207(1):68-73. PubMed ID: 19473657
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.
Brånén L; Hovgaard L; Nitulescu M; Bengtsson E; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2137-42. PubMed ID: 15345516
[TBL] [Abstract][Full Text] [Related]
23. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
24. Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice.
Choy K; Beck K; Png FY; Wu BJ; Leichtweis SB; Thomas SR; Hou JY; Croft KD; Mori TA; Stocker R
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1684-90. PubMed ID: 15961704
[TBL] [Abstract][Full Text] [Related]
25. Effects of the factor Xa inhibitor, fondaparinux, on the stability of atherosclerotic lesions in apolipoprotein E-deficient mice.
Zuo P; Zhou Q; Zuo Z; Wang X; Chen L; Ma G
Circ J; 2015; 79(11):2499-508. PubMed ID: 26346031
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging.
Takeda M; Yamashita T; Shinohara M; Sasaki N; Tawa H; Nakajima K; Momose A; Hirata K
Int J Cardiovasc Imaging; 2012 Jun; 28(5):1181-91. PubMed ID: 21688134
[TBL] [Abstract][Full Text] [Related]
27. Eplerenone reduced lesion size in early but not advanced atherosclerosis in apolipoprotein E-deficient mice.
Raz-Pasteur A; Gamliel-Lazarovich A; Coleman R; Keidar S
J Cardiovasc Pharmacol; 2012 Dec; 60(6):508-12. PubMed ID: 23232789
[TBL] [Abstract][Full Text] [Related]
28. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
[TBL] [Abstract][Full Text] [Related]
29. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice.
Yeganeh B; Moshtaghi-Kashanian GR; Declercq V; Moghadasian MH
J Nutr Biochem; 2005 Apr; 16(4):222-8. PubMed ID: 15808326
[TBL] [Abstract][Full Text] [Related]
30. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
[TBL] [Abstract][Full Text] [Related]
31. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
[TBL] [Abstract][Full Text] [Related]
32. Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model.
Xiong M; Jia C; Cui J; Wang P; Du X; Yang Q; Zhu Y; Wang W; Zhang T; Chen Y
J Ethnopharmacol; 2015 Jan; 159():84-92. PubMed ID: 25449459
[TBL] [Abstract][Full Text] [Related]
33. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
34. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
36. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
37. Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis.
Li JJ; Meng X; Si HP; Zhang C; Lv HX; Zhao YX; Yang JM; Dong M; Zhang K; Liu SX; Zhao XQ; Gao F; Liu XL; Cui TX; Zhang Y
Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1158-66. PubMed ID: 22383698
[TBL] [Abstract][Full Text] [Related]
38. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
[TBL] [Abstract][Full Text] [Related]
39. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
[TBL] [Abstract][Full Text] [Related]
40. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.
Johnson J; Carson K; Williams H; Karanam S; Newby A; Angelini G; George S; Jackson C
Circulation; 2005 Mar; 111(11):1422-30. PubMed ID: 15781753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
